About GenoPhe
GenoPhe is a Healthcare company based in Bengaluru (India) founded in 2018 by Srinath Thiruneelakantan. Phenotypic screening is performed using zebrafish to model human diseases. GenoPhe offers products and services including Nutraceutical Products. Its focus areas include Life Sciences, Genomics, Genomics Services and Sequencing. Its legal entity in India is Genophe Biotech Private Limited (U73200KA2018PTC109240).
Company details
GenoPhe was established in 2018 in Bengaluru, India, within the biotechnology sector. Zebrafish models are employed for phenotypic screening related to human genetic diseases, cancer, and infections. Libraries of molecules are screened to identify potential therapeutics. Comprehensive toxicity assessments are also conducted using the zebrafish platform. Operations focus on supporting drug discovery and safety evaluation processes.
- Headquarters Bengaluru, India
- Founders Srinath Thiruneelakantan
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website genophe.com
- Social LinkedIn X Facebook Instagram
- Legal Name Genophe Biotech Private Limited
- Date of Incorporation 05 Jan, 2018
- Jurisdiction Bengaluru, Karnataka, India
- Annual Revenue₹44,240
FY 2024 · -97% YoY
- Net Loss-₹20.5 Lakh
FY 2024 · -4623% margin
- EBITDA-₹17.3 Lakh
FY 2024 · -3900% margin
Associated legal entities of GenoPhe
GenoPhe operates through Genophe Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genophe Biotech Private Limited CIN U73200KA2018PTC109240 | Active | 05 Jan 2018 | Bangalore, Karnataka | ₹0.0 Cr | 4 | View details |
Products & Services of GenoPhe
GenoPhe offers a comprehensive portfolio of products and services, including Nutraceutical Products.
Science-backed items for enhancing metabolic health and well-being
Board of directors of Genophe Biotech Private Limited (GenoPhe)
Genophe Biotech Private Limited is the primary company behind GenoPhe. The board of Genophe Biotech Private Limited currently have 4 directors; the longest-serving is Thiruneelakantan Srinath, appointed in 2018. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Thiruneelakantan Srinath DIN 07988037 | Director | 05 Jan 2018 | 8 yrs 10 mo | Genophe Biotech Private Limited |
| Kalastauadi Chandrashekar Tejus Baba DIN 08250602 | Director | 05 Oct 2018 | 8 yrs 1 mo | Genophe Biotech Private Limited |
| Kasi Rajgopal DIN 08311467 | Director | 12 Dec 2018 | 7 yrs 11 mo | Genophe Biotech Private Limited |
| Geetika Singh DIN 08820827 | Director | 05 Aug 2020 | 6 yrs 3 mo | Genophe Biotech Private Limited |
People of GenoPhe
1 people are tracked at GenoPhe (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder & MD | Leadership |
Complete people profiles for GenoPhe
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of GenoPhe
Figures of Genophe Biotech Private Limited, the primary company behind GenoPhe, for FY 2024. Revenue was ₹44,240 (-97% year on year). Net loss was -₹20.5 Lakh (-4623% margin). EBITDA was -₹17.3 Lakh (-3900% margin). Revenue has grown at a compounded annual rate of -71% over three years and +24% over five years.
- ₹44,240Revenue · FY 2024 · -97% YoY
- -₹20.5 LakhNet loss · -4623% margin
- -₹17.3 LakhEBITDA · -3900% margin
- ₹1.1 LakhPaid-up capital
- -71%Revenue CAGR, 3 years
- +24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Genophe Biotech Private Limited are on its company page.
Detailed financial statements for GenoPhe
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GenoPhe
GenoPhe was founded in 2018.
GenoPhe is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
The primary company behind GenoPhe, Genophe Biotech Private Limited, reported revenue of ₹44,240 for FY 2024, down 97% year on year.
GenoPhe was established in 2018 in Bengaluru, India, within the biotechnology sector. Zebrafish models are employed for phenotypic screening related to human genetic diseases, cancer, and infections. Libraries of molecules are screened to identify potential therapeutics. Comprehensive toxicity assessments are also conducted using the zebrafish platform. Operations focus on supporting drug discovery and safety evaluation processes.
GenoPhe offers Nutraceutical Products.
GenoPhe operates through Genophe Biotech Private Limited.
The legal entities of GenoPhe currently have 4 directors, including Geetika Singh, Kasi Rajgopal, Kalastauadi Chandrashekar Tejus Baba and others.